DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Afimoxifene
Afimoxifene
Phase II Study of Hormone Therapy with Tamoxifen in Patients with Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)
A Simple Method to Measure Sulfonation in Man Using Paracetamol As Probe Drug Natália Marto 1,2*, Judit Morello1,3, Alexandra M
Tanibirumab (CUI C3490677) Add to Cart
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
TE INI (19 ) United States (12 ) Patent Application Publication ( 10) Pub
Nci 2017-09-01 Phase I Trial of Endoxifen Gel Versus
Molecular Mechanisms Involved in the Protective Actions of Selective Estrogen Receptor Modulators in Brain Cells
Elucidating Binding Sites and Affinities of Erα Agonist and Antagonist to Human Alpha-Fetoprotein by in Silico Modeling and Point Mutagenesis Nurbubu T
In Vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in 2 COVID-19 3
Toremifene in Premenstrual Mastalgia
Atossa Genetics Clinical Update
Screen of FDA-Approved Drug Library Reveals Compounds That Protect Hair Cells from Aminoglycosides and Cisplatin
Diploma Thesis 2009
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy
Breast Cancer - Invasive Jane Doe 1/15/2020
Stembook 2018.Pdf
Characterization of Cytosolic Sulfotransferase Expression and Regulation in Human Liver and Intestine
Berrchem Company Ltd API List
Top View
507 Update 8/25/2018
Topical Tamoxifen Promising for Mastalgia
Hazardous Chemical Agents (Anti-Neoplastic, Carcinogens, Reproductive Hazards, Neurotoxic)
Selective Estrogen Receptor Modulators Œ an Update
Pharmaabkommen A1 E
Investigation of 7-Dehydrocholesterol Reductase Pathway to Elucidate Off-Target Prenatal Effects of Pharmaceuticals: a Systematic Review
Artemisinin and Breast Cancer
Safety of Vaginal Estrogens: a Systematic Review Supplemental
(12) Patent Application Publication (10) Pub. No.: US 2010/0278784 A1 Pojasek Et Al
Oral Low Dose and Topical Tamoxifen for Breast Cancer Prevention: Modern Approaches for an Old Drug
Atossa Genetics Acquires Rights to Clinical Stage Proprietary Afimoxifene Gel for Potential Treatment of Hyperplasia of the Breast
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Topical Tamoxifen Benefits Cyclic Mastalgia
Sulfation of Afimoxifene, Endoxifen, Raloxifene, and Fulvestrant by the Human Cytosolic Sulfotransferases
The Council of Biomedical Graduate Students 2018 Graduate Research Forum
2011 Medicines in Development for Women
Hrt Informed Consent Bicalutamide
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Study Protocol and Statistical Analysis Plan
Clinical Cancer Cancer Therapy: Clinical Research
(12) United States Patent (10) Patent No.: US 9.403,911 B2 Batra Et Al
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
Mapt Breast Sample Report EXS50068 0221
Download Product Insert (PDF)
A Dissertation Entitled Studies on the Functional Relevance of Genetic
Gungor Serms Final Accepted
In-Depth Characterization of Epiintestinal Microtissue As a Model for Intestinal Drug Absorption and Metabolism in Human